1
CURRICULUM VITAE
HOWARD AARON IAN KADER, M.D.
Assistant Professor
Director, Pediatric Inflammatory BowelDiseaseCenter
Department of Pediatrics
The University of MarylandHospital for Children
The University of MarylandSchool of Medicine
November, 2016
Contact Information:Department of Pediatrics
The University of MarylandSchool of Medicine
Division of Pediatric Gastroenterology & Nutrition
The University of MarylandHospital for Children
22 South Greene Street, Rm N5W68
Baltimore, MD21201-1595
Ph: 410-328-0812
Fax: 410-320-1072
EDUCATION:
1983-87 B.A.cum laude, 5/15/1987, WashingtonUniversity in St. Louis, MO
Major: History & Biology
Thesis “Oil and the Role of the Netherland East Indies in the
Japanese-American Far Eastern Crisis 1938-1941”
Thesis Advisor: Henry W. Berger
1988-92M.D.5/9/1992 University of NebraskaCollege of Medicine, Omaha, NE
POSTGRADUATE EDUCATION AND TRAINING:
1987-88Unclassified Student Status in the Departments of Pediatrics and Anatomy
University of NebraskaCollege of Medicine, Omaha
1992-93Intern in General Surgery
Washington Hospital Center, Washington, D.C.
1993-94Intern in Pediatrics, Creighton-Nebraska Universities Health Foundation Joint
Pediatric Residency Program
University of NebraskaMedicalCenter, Omaha
1994-96Resident in Pediatrics, Creighton-Nebraska Universities Health Foundation Joint
Pediatric Residency Program
University of NebraskaMedicalCenter, Omaha
1996-97Clinical Fellow in Pediatric Gastroenterology and Nutrition
The Children’s Hospital of Philadelphia, Philadelphia
1997-99Research Fellow in Pediatric Gastroenterology and Nutrition
The Children’s Hospital of Philadelphia, Philadelphia
CERTIFICATIONS:
1993National Board of Medical Examiners
1996American Board of Pediatrics
1999American Board of Pediatrics Subspecialty Pediatric Gastroenterology & Nutrition
2004 American Board of Pediatrics – Recertification 2004-2010
2007American Board of Pediatrics Subspecialty Pediatric Gastroenterology & Nutrition –
Recertification 2007-2013
2010 American Board of Pediatrics - enrollment in Maintenance of Certification (MOC)
10/15/10 - General Pediatrics - Meeting MOC Requirements & Pediatric
Gastroenterology - Meeting MOC Requirements
MEDICAL LICENSURES:
1993 - Nebraska (inactive status)
1995 -Commonwealth ofPennsylvania (inactive status)
1997 - New Jersey (inactive status)
1999 -North Carolina (inactive status)
2002 - Maryland
EMPLOYMENT HISTORY:
ACADEMIC APPOINTMENTS:
1996 - 1999Instructor in Pediatrics, Department of Pediatrics
University of PennsylvaniaSchool of Medicine
1999 - 2002Assistant Professor of Pediatrics, Department of Pediatrics
Duke University School of Medicine
2009 - Assistant Professor of Pediatrics, Department of Pediatrics
University of MarylandSchool of Medicine
OTHER EMPLOYMENT:
1987- 1988Cytogenetic Technologist
HattieB.MonroeCenter for Human Genetics
University of NebraskaMedicalCenter, Omaha
HOSPITAL AND ADMINISTRATIVE APPOINTMENTS:
1998 - 1999Associate, Department of Pediatrics
WestJerseyHospital - Voorhees
West Jersey Health System, NJ
1998 – 1999Assistant, General Pediatrics
The Children’s Hospital of Philadelphia
1999 - 2002Assistant, Department of Pediatrics
DukeUniversityMedicalCenter
1999 - 2001Consultant, Department of Pediatrics
Southern RegionalAreaHealthEducationCenter
CapeFearValleyMedicalCenter
2000 - 2002Associate, Department of Medicine
RaleighCommunityHospital
Duke University Health System
2002 - 2009Member of the Active Staff
Department of Pediatrics
SinaiHospital of Baltimore - 8/18/2002
2004 -2009Upper Chesapeake Medical Center
Associate, Department of Pediatrics - 5/27/2009
2004 - 2009Greater BaltimoreMedicalCenter
Associate Staff, Department of Pediatrics – 6/30/2009
2009 -Assistant Professor, Department of Pediatrics
University of MarylandSchool of Medicine
University of Maryland Medical Center 7/1/2009 -
2010 -Mount Washington Pediatric Hospital
Consultant Staff Without Admitting Privileges
Pediatric Gastroenterology, 3/17/10
2012-National Institutes of Health
Level 1 (NACI) position
Special Volunteer Appointment 6/27/2012 -
PROFESSIONAL SOCIETY MEMBERSHIPS:
National Societies:
1987 - 1988Association of Cytogenetic Technologists (ACI)
1988 - 2000American Medical Association
1993 - 2002American Academy of Pediatrics
1996 -American Gastroenterology Association
1996 -North American Society of Pediatric Gastroenterology and Nutrition
1997 - 2002Fellow of the AmericanAcademy of Pediatrics
1997 -Crohn’s and Colitis Foundation of America, Inc.
2012 - American College of Gastroenterology
Local Societies:
1988 - 1996Nebraska Medical Association
1992 - 1993Medical Society of the District of Columbia
1886 – 1998New Jersey Chapter - American Medical Association
1999 - 2002North Carolina Pediatric Society
2000 – 2001 Crohn’s and Colitis Foundation of America, North Carolina Chapter
2001 - 2002Crohn’s and Colitis Foundation of America, Carolinas Chapter
2004 -Crohn’s and Colitis Foundation of America, Maryland & Southern Delaware
Chapter
HONORS and AWARDS:
1984Dean’s List, Washington University in St. Louis
1987-88Phi Alpha Theta
2000Who’s Who in the World, 18th Edition, 2001
2002Crohn’s and Colitis Foundation of America, Carolinas Chapter
Premier Physician Recognition Award
2004Guide to America’s Top Pediatricians, Consumers’ Research Council of America
2005Guide to America’s Top Pediatricians, Consumers’ Research Council of America,
2nd edition
2007Guide to America’s Top Gastroenterologists, 1st edition, 2007, Consumers’
Research Council of America,
2013Doctors of Excellence
ADMINISTRATIVE SERVICE:
INSTITUTIONAL SERVICE:
ACADEMIC COMMITTEES AT SINAIHOSPITAL OF BALTIMORE:
2006-2009Scholarly Activity Committee, The Herman & Walter Samuelson Children’s
Hospital at Sinai
ACADEMIC COMMITTEES AT UNIVERSITY OF MARYLANDHOSPITAL FOR
CHILDREN:
2010 - Investigation Review Board UMMS Department Signatory for Pediatrics
2010 -Fellowship Scholarly Activity Oversight Committee, Univ of MD Sch of Med
2012 -Data Safety Management Committee – “Measures of Intestinal Permeability in
Univ of MD Sch of MedPreterm Neonates”
2016 -School of Medicine Council member – University of Maryland School of
Medicine
LOCAL AND NATIONAL SERVICE:
LOCAL STATE COMMITTEES:
2000 - 2001Crohn’s and Colitis Foundation of America, North Carolina Chapter
Local Coordinating Committee – RTP Area
2001 - 2002Crohn’s and Colitis Foundation of America, Carolinas Chapter – Local
Coordinating Committee – RTP Area
2004 - 2009Crohn’s and Colitis Foundation of America, Maryland & Southern
Delaware Chapter – Medical Advisory Committee
NATIONAL COMMITTEES:
2002 Member, IBD Subcommittee , North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition.
2010-2013Member, IBD Committee, North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition (10/10-10/13)
TEACHING SERVICE:
CLINICAL DUTIES:
1999Attending Physician In-patient Services, DukeUniversityMedicalCenter
2 residents, 2 interns, 2 jr. students
8 hours/day, 6 months/year
2000Attending Physician In-patient Services, DukeUniversityMedicalCenter
2 residents, 2 interns, 2 jr. students
8 hours/day, 4 months/year
2001Attending Physician In-patient Services, DukeUniversityMedicalCenter
2 residents, 2 interns, 2 jr. students
8 hours/day, 3 months/year
2002Attending Physician In-patient Services, DukeUniversityMedicalCenter
and The Herman & Walter Samuelson Children’s Hospital at Sinai
2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2003-2004Attending Physician In-patient Services, The Herman & Walter Samuelson
Children’s Hospital at Sinai
2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2005-2008Attending Physician In-patient Services, The Herman & Walter Samuelson
Children’s Hospital at Sinai
2 residents, 2 interns, 1-2 jr. students
8 hours/day, 3 months/year
2008Attending Physician In-patient Services, The Herman & Walter Samuelson
Children’s Hospital at Sinai
2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2009Attending Physician In-patient Services, The University of Maryland Hospital for
Children
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2010Attending Physician In-patient Services, The University of Maryland Hospital for
Children
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2011Attending Physician In-patient Services, The University of Maryland Hospital for
Children
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2012Attending Physician In-patient Services, The University of Maryland Hospital for
Children
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2013Attending Physician In-patient Services, The University of Maryland Hospital
Children’s Hospital
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2014Attending Physician In-patient Services, The University of Maryland Hospital Children’s Hospital
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2015Attending Physician In-patient Services, The University of Maryland Hospital
Children’s Hospital
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
2016Attending Physician In-patient Services, The University of Maryland Hospital
Children’s Hospital
1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students
8 hours/day, 4 months/year
MENTORING ACTIVITIES:
2003-20061 resident, 1 hour/monthClinical Research Project: “A Single Center Retrospective
Study on the Post-Operative Use of 6-mercaptopurine and/or Infliximab for
Pediatric Patients with Crohn’s Disease”. (Presented, North American Society for
Pediatric Gastroenterology and Nutrition, Annual Meeting, October 2006, Orlanda,
FL)
2008-20091 resident, 1 hour/monthClinical Research Project: “Utilization of Proton Pump
Inhibitors to Treat Infantile GERD: Analysis of Appropriate Indications for Use,
Efficacy, and Tolerance”
2010-20131 Fellow, Fellow’s Research Project in Pediatric Gastroenterology involving IBD
2012 - 20131 Resident, Resident’s Research Project in Pediatric Gastroenterology on IBD
2013 - 20141 Resident, Resident’s Research Project in Pediatric Gastroenterology on IBD
2013 - 20161 Medical Student’s Research Project in Pediatric Gastroenterology on Short
Bowel Syndrome
2015 - 20161 Fellow, Fellow’s Research Project in Pediatric Gastroenterology involving IBD
RESIDENT/FELLOW CONFERENCES:
DukeUniversityMedicalCenter, Durham, NC; Pediatric Resident Noon Conference
3/4/2002 “Inflammatory Bowel Disease”
DukeUniversityMedicalCenter, Durham, NC; Pediatric Resident Noon Conference
3/6/2002 “Cytokines Profile and Therapy in Inflammatory Bowel Disease –
Biologics”
DukeUniversityMedicalCenter, Durham, NC; Pediatric Resident Noon Conference
3/13/2002 “Upper GI Foreign Bodies”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 5/6/2002 “Gastroesophageal Reflux Disease”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 5/2003 “Upper GI Tract Foreign Bodies”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 9/2003 “Pediatric IBD”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 11/2003 “Pediatric IBD Medication/Management Part 1”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 12/2003 “Pediatric IBD Medication/Management Part 2”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 01/2006 “Pancreatitis in Childhood”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 01/2007 “Pediatric Gastroesophageal Reflux Disease”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 06/2007 “Total Parenteral Nutrition: The Hows and Whats To Do”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 02/20/2008 “Pediatric Inflammatory Bowel Disease”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 08/19/2008 “Total Parenteral Nutrition: The Hows and Whats To Do”
The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon
Conference 03/12/2008 “Pediatric Inflammatory Bowel Disease”
University of MarylandHospital for Children; Peds GI Fellow Conference 08/25/2009. “Anti-
TNF Medications in IBD”.
University of MarylandHospital for Children; Peds GI Fellow Conference 09/17/2009. “Non-
Anti-TNF Medications in IBD”.
University of MarylandHospital for Children; Pediatric Resident Noon Conference
02/17/2010. “Pediatric Gastroesophageal Reflux Disease”.
University of MarylandHospital for Children; Peds GI Fellow Conference 06/04/2010.
Journal Club-Article Reviews.
University of MarylandHospital for Children; Pediatric Resident Noon Conference
10/26/2010. “Medical Therapy Used in Pediatric Inflammatory Bowel Disease”.
University of MarylandHospital for Children; Peds GI Fellow Conference 11/04/2010.
Journal Club-Article Reviews.
University of Maryland Hospital for Children; Pediatric Resident Noon Conference
10/14/2013. “Diagnosis and Management of GERD in Pediatric Patients”.
University of Maryland Hospital for Children; Pediatric Resident Noon Conference
3/9/2014. “Pediatric IBD”.
University of Maryland Hospital for Children; Pediatric Resident Noon Conference
10/26/2016. “Pediatric Inflammatory Bowel Disease”.
University of Maryland Hospital for Children; Pediatric Resident Noon Conference
10/28/2016. “Biologics In Inflammatory Bowel Disease”.
GRANT SUPPORT:
COMPLETED GRANTS:
1997 100% Effort
Principal Investigator
Efficacy of Intravenous Loading of Azathioprine in Children, Adolescents, and
Young Adults with Severe Inflammatory Bowel Disease
Junior Clinical Investigator Award (non-peer-reviewed)
The GeneralClinicalResearchCenter, ($10,000 / one year)
The Children’s Hospital of Philadelphia, Philadelphia, PA
1997-98100% Effort
Principal Investigator
Efficacy of Intravenous Loading of Azathioprine in Children, Adolescents, and
Young Adults with Severe Inflammatory Bowel Disease
Nutrition Center Pilot Project (non-peer-reviewed)
Howard Heinz Endowment, ($3,000 / one year)
The Children’s Hospital of Philadelphia, Philadelphia, PA
1999-2000100% Effort
Principal Investigator
The Prevalence of Inherited Thrombotic Markers in Pediatric Patients with
Inflammatory Bowel Disease
Duke Children’s Miracle Network ($16,000 / one year)(non-peer-reviewed)
DukeUniversityMedicalCenter, Durham, NC
SPONSORED LECTURES:
2002 - 2004GERD lecture/speaker bureau for TAP Pharmaceuticals
2006 - 2009GERD lecture/speaker bureau for TAP Pharmaceuticals
PUBLICATIONS:
Peer-reviewed journal articles:
1. Kader HA, Kaufman SS, Raynor SC, Young R, Vanderhoof J, Ruby EI, Mack DR. Introduction of
6-mercaptopurine in Crohn’s disease patients during the perioperative period: A
preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr 1997;
25(1):93-97.
2. Kader HA, Ruchelli E, Maller ES. Langerhans’ cell histiocytosis presenting with stool retention
due to a perianal mass. J Pediatr Gastroenterol Nutr 1998; 26:226-228.
3. Kader HA, Baldassano RN, Harty MP, Nicotra JJ, von Allmen D, Finn L, Markowitz J, Carrier
M, Piccoli DA. A ruptured retrocecal appendicitis in an adolescent presenting as portal-
mesenteric thrombosis and pylephlebitis. J Pediatr Gastroenterol Nutr 1998; 27:584-588.
4. Kader HA, Piccoli DA, Jawad AF, McGowan KL, Maller ES. Single toxin detection is
inadequate to diagnose Clostridium difficile diarrhea in pediatric patients.
Gastroenterology 1998;115(6):1329-1334.
5. Kader HA, Mascarenhas MR, Piccoli DA, Stouffer NO, Baldassano RN. Experiences of
6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.
J Pediatr Gastroenterol Nutr 1999; 28:54-58.
6. Kader HA, Telega GW, Wenner WJ, Rand EB, Maller ES, Baldassano RN. Normal thiopurine
methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in
children with inflammatory bowel disease. J Clin Gastro 2000; 30(4):409-413.
7. Kader HA, Mascarenhas MR, Verma R, Collins M, Ruchelli E, Baldassano RN. Colonic
Inflammation Found at Diagnosis of Juvenile Retention Polyps in Pediatric Patients.
Am J Gastroenterol 2000; 95(8):1990-1993.
8. Kader HA, Berman WF, Al-SeraihyAS, Ware RE, Ulshen MH, Treem WR. “Prevalence of
Factor G1691A (Leiden), Prothrombin G20210A and Methylene Tetrahydrofolate
Reductase C677T Thrombophilic Mutations in Children with Inflammatory Bowel
Disease”. J. Pediatr Gastroenterol Nutr 2002; 35(5):629-635.
9. Kader HA, Bellah RD, Maller ES, Mamula P, Piccoli DA, Markowitz JE. The utility of
ultrasound site selection for pediatric percutaneous liver biopsy. J. Pediatr
Gastroenterol Nutr 2003; 36(3): 364-367.
10. Kader HA, Tchernev VT, Satyaraj E, Lejnine S, Kotler G, Kingsmore SF, Patel DD. Protein
Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease
Demonstrates Elevated Serum PLGF, IL-7, TGF-1 and IL-12p40 levels in Crohn’s
Disease and Ulcerative Colitis Patients in Remission versus Active Disease. Am. J.
Gastroenterol 2005; 100(2):414-423.
- Colletti, RB, Baldassano, RN, Milov, DE, Margolis, PA, Bousvaros, A, Crandall, WV,
Crissinger, KD, D’Amico, MD, Day, AS, Denson, LE, Dubinsky M, Ebach, DR,
Hoffenberg, EJ, Kader, HA, Keljo, DJ, eibowitz, IA, Mamula, P, Pfefferkorn, MD,
Qureshi, MA for PIBDNet—the Pediatric IBD Network for Research and Improvement.
Variation in Care inPediatric Crohn’s Disease. J. Pediatr Gastroenterol Nutr.
2009;49(3):297-303.
- Ming-Hsi Wang, MD, PhD, Toshihiko Okazaki, MD, PhD, Subra Kugathasan, MD, Judy H.
Cho, MD, Kim L. Isaacs, MD, James D. Lewis, MD, Duane T. Smoot, MD, John F.
Valentine, MD,Howard A. Kader, MD, Jean G. Ford, MD, Mary L. Harris, MD, Maria
Oliva-Hemker, MD,Carmen Cuffari, MD, Michael S. Torbenson, MD, Richard H. Duerr,
MD, Mark Silverberg, MD, PhD, John D. Rioux, PhD, Kent D. Taylor, PhD, Geoffrey C.
Nguyen, MD, PhD, Yuqiong Wu, MD, Lisa W. Datta, MSc, Stanley Hooker, BS,
Themistocles Dassopoulos, MD, Rick A. Kittles, PhD Linda W.H. Kao, PhD, Steven R.
Brant, MD. Contribution of Higher Risk Genes and European Admixture to Crohn’s
Disease in African Americans. Inflammatory Bowel Disease Journal. 2012;18(12):2277-
2287. (published online3/12/2012, DOI: 10.1002/ibd.22931).
- Kader, HA, Martin, M, Twaddell WS, Drachenberg, CI, Jinadu LA. Periorbital Edema and
Abdominal Distension: Beyond Celiac Disease. Consultant For Pediatricians. 2013;
12(9):406-410.
- DeZoeten, E. Mattei, P. Pasternak, B. Kramer, R. Kader, HA. Perianal Crohn's disease
Clinical report/Consensus statement for NASPGHAN. J. Pediatr Gastroenterol Nutr.
2013; 57(3):401-412.
15.Booth, Jayaum S, Toapanta, Franklin R. Salemo-Goncalves, Rosangela. Patil, Seema.
Kader, Howard. Safta, Anca. Czinn, Steve. Greenwald, Bruce. and Sztein, Marcelo B.,
Characterization and functional properties of gastrictissue-resident memory T cells from
Children, adults and the elderly. Front Immunol. 2014, (294):1-5.
- Booth, JS, Salerno-Goncalves, R, Blanchard, TG, Patil, SA, Kader, HA, Safta, AM,
Morningstar,LM, Czinn, SJ, Greenwald, BD and Sztein MB. Mucosal Associated Invariant T
cells in the human gastric mucosa and blood: Role in Helicobacter pylori infection.
Front Immunol. 2015, 6:466
- Chengrui Huang, Talin Haritunians, David T. Okou,David J. Cutler, Michael E. Zwick,Kent D.
Taylor,Lisa W. Datta,Joseph C. Maranville, Zhenqiu Liu, Shannon Ellis,Pankaj Chopra,
Jonathan S. Alexander, Robert N. Baldassano, Raymond K. Cross,Themistocles
Dassopoulos,Tanvi A. Dhere,Richard H. Duerr, John S. Hanson,Jason K. Hou,Sunny
Z. Hussain,Kim L. Isaacs,Kelly E. Kachelries, Howard Kader,Michael D. Kappelman,
Jeffrey Katz,Richard Kellermayer, Barbara S. Kirschner,John F. Kuemmerle,Archana
Kumar,John H. Kwon, Mark Lazarev,Peter Mannon,Dedrick E. Moulton,Bankole O.
Osuntokun, Ashish Patel,John D. Rioux,Jerome I. Rotter,Shehzad Saeed,Ellen J.
Scherl, Mark S. Silverberg,Ann Silverman,Stephan R. Targan,John F. Valentine, Ming-
Hsi Wang,Claire L. Simpson,S. Louis Bridges,Robert P. Kimberly, Stephen S. Rich,
Judy H. Cho,Anna Di Rienzo,Linda W. H. Kao, Dermot P. B. McGovern,Steven R.
Brant, and Subra Kugathasan. Characterization of Genetic Loci That Affect Susceptibility
to Inflammatory Bowel Diseases in African Americans. Gastroenterology
2015;149(6):1575–1586.
- Brant, SR , Okou, D , Simpson, CL, Cutler, D, Haritunians, T, Bradfield, J, Chopra, P, Prince,
J, Begum, F,Kumar, A, Huang, C, Venkateswaran, S, Wei, Z , Thomas, KA, Herrinton, L,
Klapproth, JM , Quiros,A, Seminerio, J. Liu, J,Alexander, J , Baldassano, RN, Dudley-
Brown, S, Cross, R, Dassopoulos, T , Dhere, T, Dryden, G, Hanson,J, Hou, J, Hussain,S,
Denson, L, Hyams, J, Mack, D, Isaacs, K ,Kader, H, Kappelman, H , Katz, J,
Kellermayer, R, Kirschner,B ,Kuemmerle, J , Kwon. J, Li E. Mannon, P, Moulton, D,
Newberry,R, Osuntokun, B,Patel,A, Saeed,S, Targan,S, Valentine, J, Wang, MH
Lazarev, M, Zonca, M , Datta, L, Rioux, J, Duerr,R, Silverberg,M, Cho,J, Hakonarson,H,
Zwick,M and McGovern, D.Genome-wide Association Identifies African-Specific
Susceptibility Loci in African Americans with Inflammatory Bowel Disease.
(Gastroenterol. 2016 accepted)
- Brant, SR, Paul, A, Kader, HA, Huang, C, DeRavin, SS and Malech, H. Genetic Risk for Inflammatory Bowel Disease is a Determinant of Crohn’s Disease Development in Chronic Granulomatous Disease. (Inflammatory Bowel Disease, 2016, accepted)
Non-peer reviewed journal articles:
- Kader HA, Ing P, Buehler B, Sanger W. Cytogenetic confirmation of clinical diagnosis in
Nebraska.Nebr Med J 1990; 75(8):236-238.
- McGowan KL, Kader HA. Clostridium difficile Infection in Children. Clinical Microbiology
Newsletter 1999; 21(7):49-53.
Book Chapters:
- Kader HA, Liacouras CA. Abdominal Pain. In: Altschuler SM and LiacourasCA eds. Clinical
Pediatric Gastroenterology. Philadelphia; Churchill Livingstone, 1998, 5-8.
- Jacobstein D, Kader HA, Antibiotic Therapy, In: Mamula P, Markowitz JE and Baldassano RN
eds. PediatricInflammatory Bowel Disease. New York; Springer Science+Business
Media, LLC, 2008, 329-336.
- Contributing author, Kader HA, Transitions from Pediatric to Adult Healthcare Provider. In:
Oliva-Hemker M, Ziring D and Bousvaros A eds-in-chief. Your Child with Inflammatory
Bowel Disease: A Family Guide for Caregiving. Baltimore; The JohnsHopkinsUniversity
Press, 2010, 232-235.
- Kader HA, Jacobstein D, Paul A. Chapter 27 Antibiotic Therapy, In: Mamula P, Markowitz JE
and Baldassano RN eds. Pediatric Inflammatory Bowel Disease. 2nd Ed.New York;
Springer Science+Business Media, LLC, 2013.
- Kader HA, Paul A, Albenberg, L. Chapter 27 Antibiotic Therapy, In: Kelsen, AB and Judith R eds. Pediatric Inflammatory Bowel Disease. 3rd Ed.New York; Springer Science+Business Media, LLC, (in process)
Abstracts and/or Proceedings:
1. Kader HA, Sanger W, Fordyce R. Cytogenetic confirmation of clinical diagnosis in the Nebraska
area. Karyogram: J Cytogenetic Tech 1988; 14(4):70.
(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,
Canada.)
2. Heck D, Sanger W, Severa S, Kader H. Establishment of breakage frequency in lymphocyte
cultures induced by Fragile X media. Karyogram: J Cytogenetic Tech 1988; 14(4):69.
(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,
Canada.)
- Severa S, Sanger W, Heck D, Kader H. Establishment of breakage frequency in lymphocyte
cultures induced by actinomycin-D. Karyogram: J Cytogenetic Tech 1988; 14(4):75-76.
(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,
Canada.)
- Kader HA, Kaufman SS, Vanderhoof JA, Young R, Raynor SC, Ruby EI, Mack DR.
Introduction of 6-mercaptopurine in Crohn’s disease patients during the perioperative
period. J Pediatr Gastroenterol Nutr 1996; 23(3):365.